GlassScriptPhysician profile
Stacy R Beaty
NPI 1669499638
$14,381.66
in general payments reported to CMS, 2019-2025
40 companies · $2,808 in 2025
The $2,808 reported for 2025 was more than what 83% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,082 · 2020: $1,284 · 2021: $1,718 · 2022: $2,426 · 2023: $2,133 · 2024: $1,932 · 2025: $2,808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,818 · Consulting Fee: $875 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,817.72 |
| Consulting Fee | $875.00 |
| Education | $179.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,656.55 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Abbvie INC. | $2,578.83 | 2019-2025 | Rinvoq, Skyrizi |
| Genzyme Corporation | $1,455.78 | 2019-2025 | |
| Galderma Laboratories, L.P. | $1,087.83 | 2019-2025 | Nemluvio |
| Novartis Pharmaceuticals Corporation | $747.96 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $662.51 | 2019-2024 | Winlevi, Absorica Ld |
| Regeneron Healthcare Solutions, INC. | $597.96 | 2019-2025 | Dupixent |
| Pfizer INC. | $483.31 | 2019-2025 | |
| Amgen INC. | $461.72 | 2019-2025 | Otezla, Otezla |
| Merz North America, INC. | $370.09 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $360.53 | 2022-2024 | Sotyktu |
| Lilly USA, LLC | $353.13 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $286.38 | 2023-2025 | Bimzelx |
| Incyte Corporation | $264.45 | 2021-2025 | Opzelura |
| Almirall LLC | $244.20 | 2019-2025 | Klisyri, Seysara |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Beaty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.